< BACK Ongoing preparation for the iPROLEPSIS-PDPID study Mar 4, 2024 iPROLEPSIS-PDPID Study: Advancing Psoriatic Arthritis through Innovative Digital Biomarkers Patients with Psoriatic arthritis (PsA) experience difficulties in dealing with unpredictable disease activity, which can affect their quality of life. Developing a digital biomarker using a smartphone and smartwatch would allow for unobtrusive monitoring of the disease activity in these patients. Besides, understanding what factors trigger flare would allow for better disease control. The iPROLEPSIS-PDPID study is a multicentre observational cohort study that aims to develop an unobtrusive and affordable digital biomarker capable of detecting changes in disease activity, including flare, and to identify triggers of flare in patients with PsA. The study will be conducted in four countries: the Netherlands, the UK, Portugal and Greece. Ethical approval for initiating the iPROLEPSIS-PDPID study in the Netherlands and the UK has been granted. The OpenClinica platform will be used in the collection and storage of data for the iPROLEPSIS-PDPID study. Future steps include obtaining ethical approvals for Portugal and Greece as well as local approvals from centres participating in each country, and inclusion of patients from each participating country. The miPROLEPSIS phone app , currently under development, will be used in this study. The app will be installed on the patient smartphone and utilised as a data collector, which will be then used for algorithms development and training. The app will measure physical activity, the length of sleep, self-registered flare, and register daily pain, fatigue, sleep and morning stiffness. The Garmin smartwatch Vivoactive 5 device will be used to collect data on physical activity, heart rate, heart rate variability and sleep quality. The collected data from Garmin will be downloaded from the miPROLEPSIS app by Wellics software (developer in the project), which allows extracting, visualising and exporting collected both company-processed data, as well as raw data. 10.png 13.png 14.png 10.png 1/5 PREVIOUS NEXT

< BACK iPROLEPSIS Presented at Health Data Summit 2025 Mar 27, 2025 Showcasing practical strategies for high-quality data mapping and harmonisation At Health Data Summit 2025 , organised by the European Institute for Innovation Through Health Data (i~HD) on March 18–19 in Brussels , the iPROLEPSIS project was presented by Thanos Vidakis from AINIGMA Technologies . The presentation was part of the session titled: "Advanced Strategies and Tools for Ensuring High-Quality Data During Data Mapping". It focused on how iPROLEPSIS uses the OMOP Common Data Model (CDM) and OHDSI tools to harmonize health datasets from various sources. By applying coding standards such as SNOMED , the project ensures consistency and interoperability across data systems. The talk also highlighted recent hands-on workshops with data experts , during which real-world data was mapped to the OMOP model and underwent quality checks . These steps are essential in delivering analytics-ready health data — a key goal of the project. iPROLEPSIS continues to support high standards in digital health research by promoting data quality, standardisation, and collaboration across partners. 1/2 PREVIOUS NEXT

Learning Hub Explore resources to help you understand and manage psoriatic arthritis. Learning hub Key Facts Handbook News Feed Quizzes Search How will psoriatic arthritis affect me? Relationships and Family Planning See related Handbook section PREVIOUS NEXT

< BACK iPROLEPSIS Games Presented at Centro Neurológico de Torres Vedras Jul 21, 2026 The visit offered an opportunity to present the iPROLEPSIS Games and discuss the project’s work with the centre’s team On 8 July 2026, the Faculdade de Motricidade Humana from University of Lisbon team visited the Centro Neurológico de Torres Vedras in Portugal to present the iPROLEPSIS Games. The visit provided an opportunity to introduce the iPROLEPSIS games, share the team’s work and exchange insights with the centre’s staff. The iPROLEPSIS Games are being developed as part of the project’s work on digital tools for people with psoriatic arthritis. cns4.png cns2.jpeg cns1.jpeg cns4.png 1/3 PREVIOUS NEXT

< BACK Seasons Greetings from iPROLEPSIS Dec 23, 2025 Happy holidays and best wishes for the year ahead! We wish you a warm and peaceful holiday season. May the coming year bring good health, positive moments, and new opportunities. Happy holidays! iPROLEPSIS iPROLEPSIS Happy Holidays.png iPROLEPSIS Happy Holidays.png 1/1 PREVIOUS NEXT

< BACK iPROLEPSIS Games Selected for HiTech 2025 Feb 13, 2025 Transforming Research into Real-World Solutions The iPROLEPSIS consortium partners from FMH/IST-ULisboa are pleased to announce that iPROLEPSIS Games has been selected as one of the 16 teams for the HiTech 2025 Program . HiTech 2025, organised by HiSeedTech , supports research teams in transforming deep tech innovations into market-ready solutions . This selection marks an exciting step forward for iPROLEPSIS Games , reinforcing our commitment to bridging the gap between scientific research and practical applications . 🔗 Read more about the program: HiSeedTech: Programs 1/1 PREVIOUS NEXT

< BACK iPROLEPSIS Clinical Studies' Planning Feb 13, 2023 iPROLEPSIS team starts the planning of the four clinical studies that will be conducted in the project. iPROLEPSIS team starts the planning of the four clinical studies that will be conducted in the project. iPROLEPSIS plans to carry out: 1) a study to design novel digital biomarkers for PsA; 2) a study to investigate new opto-acoustics biomarkers and the role of mast cells in PsA; 3) a study to validate the potential of the novel digital biomarkers to screen for PsA in persons with psoriasis; and 4) a study to evaluate the effectiveness of the envisioned iPROLEPSIS digital care ecosystem in reducing flares of persons with PsA. Office Scene .jpg Office Scene .jpg 1/1 PREVIOUS NEXT

< BACK The iPROLEPSIS Learning Hub Has Been Renewed Oct 14, 2025 A refreshed space to learn more about psoriatic arthritis The iPROLEPSIS Learning Hub has been renewed with a new design, structure, and additional content to make exploring its materials more intuitive and engaging. The updated platform offers accessible information and practical resources related to psoriatic arthritis , supporting users who wish to learn more about the condition and its management. Explore resources on psoriatic arthritis The renewed Learning Hub brings together several sections that guide visitors through different aspects of the condition: Psoriatic Arthritis Handbook – an overview of psoriatic arthritis, including symptoms, diagnosis, and management. Key Facts – short explanations and definitions to help understand key topics. Interactive Quizzes – quick checks to support learning in an engaging way. News Feed – a selection of updates and materials from external, recognised sources. A space to learn and stay informed The Learning Hub offers a simple way to explore information about psoriatic arthritis and to learn more about its characteristics, treatment approaches, and impact on daily life. Visit the renewed Learning Hub : https://www.iprolepsis.eu/learning-hub-new iPROLEPSIS_Learning Hub.png iPROLEPSIS_Learning Hub.png 1/1 PREVIOUS NEXT

< BACK Innovating Psoriatic Arthritis Care with iPROLEPSIS Oct 29, 2024 Insights Shared in Psoriasis Magazine: An Interview with Psoriasis Patienten Nederland We are pleased to share that we were interviewed by Psoriasis Patients Netherlands ( https://psoriasispatientennederland.nl/ ) and featured in their Psoriasis Magazine . This dedicated volunteer organisation advocates for over 300,000 people in the Netherlands affected by psoriasis and psoriatic arthritis. Supporting Patients Psoriasis Patients Netherlands provides clear, unbiased information on managing chronic conditions and serves as a vital link between patients, healthcare providers, and the latest research. Their focus is on patient support, offering resources like their magazine, social media, and direct support channels, creating an invaluable network for those navigating these challenging conditions. Digital Health Innovation The Erasmus MC in Rotterdam, through the iPROLEPSIS Consortium , is developing an app to help patients with psoriatic arthritis monitor their condition using digital health tools. Over 600 patients across four countries will use the app and smartwatches to track their heart rate, activity, and symptoms daily, along with periodic video analyses and healthcare visits. Key Research Areas The key research areas include exploring the roles of genetics, gut microbiome, and lifestyle factors. Collaborations with organizations like HPOS will soon allow individuals with psoriasis to contribute their data, supporting predictive models for earlier diagnosis. Empowering Patients Through Partnership The Erasmus MC’s iPROLEPSIS study is not just about technological development; it is driven by the stories of patient partners like Elaine and Wendy. Their lived experience with psoriatic arthritis informs our work, ensuring that the tools we develop support their needs and enhance their well-being. With patient partners at the core of the iPROLEPSIS initiative, we are creating a future where digital tools empower psoriatic arthritis patients. 1/1 PREVIOUS NEXT

< BACK Maximising Project Impact: iPROLEPSIS Exploitation Strategy Seminar with Horizon Results Booster Jun 27, 2024 Maximising Project Impact: Effective Exploitation Strategies On 26 June 2024, iPROLEPSIS held an online Exploitation strategy seminar led by Horizon Results Booster expert Emmanuel Sofianopoulo. The seminar focused on introducing consortium partners to exploitation concepts and helping to develop an exploitation strategy for project results. Key points covered included: Introduction to exploitation and exploitation plans, Key Exploitable Results (KER), and the difference between exploitation and dissemination. We also participated in a workshop for a specific KER, involving: A session to introduce the KER. Further development and refinement of the Characterisation Table, risk map and outlining the Exploitation Roadmap. Excited to apply these strategies as we move forward with our project goals! 1/8 PREVIOUS NEXT

< BACK Workshop at PETRA 2024: Advancing Personalised Health Through Multimodal Sensing and Innovative Environments Jan 25, 2024 Exploring the Future of Healthcare: AI-PROGNOSIS and iPROLEPSIS Projects Collaborate for Workshop on Human Health, Habits, and Behavior The workshop "AGENT - MultimodAl SiGnal Sensing/Analysis, Innovative Interactive Environments, and PersoNalized Behavioral Modeling for Improving QualiTy-of-Life" has been accepted in PETRA 2024! The workshop will be organised by the Centre for Research & Technology Hellas , Aristotle University of Thessaloniki , and Faculdade de Motricidade Humana in cooperation with the AI-PROGNOSIS and iPROLEPSIS projects. More info about the workshop: http://www.petrae.org/workshops/AGENT.html AI-PROGNOSIS is a Horizon Europe-funded project developing Artificial intelligence-based solutions for #Parkinson 's disease risk assessment and prognosis. iPROLEPSIS is a Horizon Europe-funded project developing a novel personalised digital care ecosystem for people with #Psoriatic #arthritis . The workshop aims to attract an interdisciplinary group of researchers involved in research related to early detection, assessment and monitoring of human health, habits and behaviour. The workshop will focus on novel technologies applied in real or virtual environments and aim to enhance the quality of daily living, especially for people with disabilities or patients suffering from chronic conditions. About PETRA 2024: PETRA (PErvasive Technologies Related to Assistive Environments) is a premier interdisciplinary conference focusing on computational and engineering approaches to enhance human performance and improve the quality of life. Join us in exploring the latest advancements in assistive technologies across various settings. More info: http://www.petrae.org/index.html Looking forward to an enriching exchange of ideas and knowledge at PETRA 2024! Banner1-2024.png Banner1-2024.png 1/1 PREVIOUS NEXT

< BACK iPROLEPSIS presented at the 2024 HIMSS European Health Conference Jun 11, 2024 Showcasing AI-Based Solutions for Psoriatic Arthritis Care Our project partner, PLUX Biosignals , participated in the 2024 HIMSS European Health Conference and Exhibition , where they showcased the innovative work of the iPROLEPSIS project, developing a novel personalised digital care ecosystem for people with psoriatic arthritis. The 2024 HIMSS European Health Conference and Exhibition was a major event for the European digital health community, bringing together approximately 2,500 healthcare executives, practitioners and professionals from 84 different countries in Rome. Held from May 29 to 31, the conference showcased the latest advancements in healthcare technology and provided a platform for critical discussions on the future of digital health in Europe and worldwide. HIMSS24 Europe addressed the region’s strategic initiatives in digital health, including the AI Act and the European Health Data Space, which aim to position Europe as a leader in digital health. HIMSS_iPROLEPSIS (2).jpg HIMSS_iPROLEPSIS (1).jpg HIMSS_iPROLEPSIS (2).jpg 1/2 PREVIOUS NEXT